Free Delivery for Orders Above Ksh. 2,999

NUCALA (MEPOLIZUMAB) 100MG 1ML INJ

Product code: nuc-177323962919217

(0 reviews)

Available in stock

An IL-5 antagonist monoclonal antibody reducing eosinophil counts for add-on maintenance in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.

Ksh 339,999

WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR?

Nucala contains mepolizumab, a biological medicine (a medicine made from living cells) that targets a specific protein in the immune system called interleukin-5 (IL-5).

IL-5 is a signalling molecule that drives the production and survival of eosinophils — a type of white blood cell that is central to the inflammation underlying certain severe forms of asthma and other conditions.

By blocking IL-5, mepolizumab reduces eosinophil levels in the blood and airways, which in turn reduces inflammation, makes asthma easier to control, and significantly reduces the risk of serious asthma attacks (called exacerbations).

Your specialist may prescribe Nucala for: severe eosinophilic asthma — uncontrolled despite high-dose inhaled medicines and other treatments, where blood eosinophil counts are elevated; eosinophilic granulomatosis with polyangiitis (EGPA — a rare autoimmune condition causing inflammation of blood vessels, previously called Churg-Strauss syndrome); and hypereosinophilic syndrome (HES — a rare condition of persistently very high eosinophil counts causing organ damage).

 

3. HOW TO TAKE THIS MEDICINE

For severe asthma and EGPA: 100mg injected under the skin (subcutaneous injection) once every 4 weeks (once a month).

For HES: 300mg (three 100mg injections at separate sites) once every 4 weeks. The injection is given by a healthcare professional in a clinic, or you or a carer may be trained to self-inject at home after proper training. Inject into the upper arm, thigh, or abdomen. Rotate injection sites.

 

Nucala is a long-term add-on treatment — it does not replace your existing inhalers. Continue all your regular asthma inhalers and medicines as prescribed. Nucala reduces the frequency and severity of asthma attacks over time, but it is not a rescue inhaler and will not provide immediate relief during an acute attack. Always keep your reliever inhaler (usually salbutamol/albuterol) with you at all times.

 

PATIENT TIP: Take Nucala out of the fridge about 30 minutes before injecting to allow it to warm to room temperature — this makes the injection more comfortable. Do not try to speed this up by heating it. After injecting, apply gentle pressure to the site for a few seconds but do not rub it.

 

4. POSSIBLE SIDE EFFECTS

How Common?

Side Effects

Common

Headache, back pain, injection site reactions (redness, swelling, itching, or pain at the injection site), fatigue, urinary tract infections, upper respiratory tract infections (colds), nasal congestion

Less Common

Allergic reactions (rash, hives, flushing)

Serious — Seek Emergency Help

Anaphylaxis (severe allergic reaction): difficulty breathing, throat swelling, dizziness, collapse — seek emergency care immediately. This is rare but can occur within minutes to hours of injection. Herpes zoster (shingles) reactivation — if you develop a painful blistering rash, contact your doctor promptly.

 

5. WHO SHOULD NOT TAKE THIS MEDICINE

Nucala should not be used during an acute asthma attack or for acute worsening of asthma — it is a preventative medicine, not a rescue treatment. It should not be used in people with known hypersensitivity to mepolizumab.

Use with caution in people with pre-existing helminth (parasitic worm) infections, as blocking IL-5 may reduce the body's ability to fight these parasites. Pregnancy and breastfeeding: discuss with your specialist — limited data available.

 

NOT A RESCUE INHALER: Nucala prevents asthma attacks over time but cannot stop an attack that is already happening. Always keep your reliever (blue) inhaler with you. If you have a severe asthma attack, use your reliever and call emergency services if it does not improve.

DO NOT STOP OTHER MEDICINES: Do not reduce or stop your inhalers, oral steroids, or other asthma medicines without your specialist's guidance — even if your asthma feels much better on Nucala. Changes to your medicines should only be made under medical supervision.

ANAPHYLAXIS RISK: Although rare, a severe allergic reaction can occur. The injection is usually given in a clinical setting where you can be observed for 30 to 60 minutes afterwards. Report any new rash, breathlessness, or throat tightening immediately.

 

6. MEDICINES THAT INTERACT WITH THIS TREATMENT

No significant drug interactions have been identified with mepolizumab. It is a biological medicine targeting a specific immune pathway and does not interact with most conventional medicines. However, always tell your respiratory specialist and pharmacist about all medicines you take, including over-the-counter products and other biological medicines.

 

7. HOW TO STORE THIS MEDICINE

Store in a refrigerator at 2–8°C. Do not freeze or shake. Protect from light. Once removed from the fridge, allow to reach room temperature before use (approximately 30 minutes). Use within the time specified after removal from fridge. Keep out of reach of children.

 

8. PRESCRIPTION REQUIREMENT

Field

Details

Status

Prescription Only Medicine (POM) — Specialist (respiratory medicine / immunology) prescription required; usually requires formal eligibility criteria review for severe asthma (e.g. elevated blood eosinophil count)

 

9. GUIDANCE FOR PATIENTS & CAREGIVERS

Nucala is given as a monthly injection under the skin — either in clinic or at home once you are trained. Remove from the fridge 30 minutes before injecting and allow to warm to room temperature.

Continue all your regular inhalers and medicines as prescribed — Nucala works alongside them, not instead of them. Always carry your reliever inhaler with you. After each injection, check the site for any unusual swelling or reaction and report it. Attend all monthly injection appointments — consistency is important for the medicine to work. If you notice your asthma worsening between injections, contact your respiratory team promptly.

 

10. PHARMACIST & PRESCRIBER NOTES

Field

Details

Clinical Dispensing Notes

Biological anti-IL-5 monoclonal antibody — confirm eligibility criteria before dispensing (eosinophil count threshold met, confirmed severe eosinophilic asthma uncontrolled on existing therapy). Cold chain: 2–8°C; do not freeze or shake. Allow to reach room temperature 30 minutes before injection. Self-injection training documentation must be confirmed before home supply. Anaphylaxis risk — first injection in supervised clinical setting recommended; anaphylaxis kit available. Counsel explicitly: Nucala is preventative, not acute rescue — reliever inhaler must be maintained at all times. Steroid sparing is a treatment goal — do not discontinue oral corticosteroids abruptly; taper under specialist guidance. Monthly injection schedule adherence counselling. Helminth infection screening in patients from endemic areas.

 

11. FREQUENTLY ASKED QUESTIONS

Q: Will Nucala replace my inhalers?

No — Nucala works alongside your inhalers, not instead of them. Keep using all your regular inhalers as prescribed. Over time, your specialist may be able to reduce your steroid tablets if your asthma improves, but this will be done gradually and only under supervision.

Q: How long before I notice it working?

Many patients notice fewer asthma attacks and improved day-to-day breathing within the first 3 to 6 months. Some improvement in symptoms can be noticed earlier, but give it time — biological medicines like mepolizumab build their effect gradually.

Q: Can I inject it myself at home?

Yes — once you have been trained by a nurse and are comfortable with the technique, home self-injection is an option. Your specialist team will organise training before setting you up for home injections.

Q: What do I do if I have an asthma attack between injections?

Use your reliever (blue) inhaler immediately. If it is not working, call emergency services. Nucala prevents attacks, but cannot stop one that is already happening — your reliever inhaler is still essential.

Q: How long will I need to take Nucala?

Severe eosinophilic asthma is a long-term condition, and most patients benefit from ongoing mepolizumab treatment. Your specialist will review whether the medicine is still working and needed at regular intervals.


 

There are no product reviews yet.


Related Products


Recently Viewed